The global urology device market is estimated to be valued at USD 20,153.3Mn in 2025 and is expected to reach USD 28,075.4 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.85% from 2025 to 2032.
The urology device market is experiencing strong growth due to the rise in burden of urologic conditions and increasing geriatric (aging) population around the world. Moreover, rise in demand or adoption of urology devices and research and development (R&D) in the field of urology is expected to boost the growth of the urology device market. However, factors such as high cost of urology devices and stringent rules and regulations are expected to hamper the market growth.
|
Current Events |
and its impact |
|
Aging Global Population and Rising Urological Disorders |
|
|
AI Integration and Robotic Surgery Advancement |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Intelligent and digital innovations have taken over the global urology devices market in 2025 with integrations of intelligence, precision, and patient-centric functionality to meet evolving clinical and healthcare demands. In this market, smart urology devices refer to solutions integrated with advanced technologies such as AI-assisted diagnostics, robotic-assisted surgery, smart endoscopy, sensors, and real-time patient monitoring systems to bring improvement in clinical outcomes, safety, and efficiency.
The incidence of renal disorders, urological malignancies, and BPH is on the rise, along with aging populations. This is driving the adoption of technologically advanced devices in the field of urology. The need for cost-effective and minimally invasive solutions has also paved the way for the development of disposable instruments, single-use catheters, and portable monitoring devices.
For example, in October 2025, Johnson & Johnson MedTech announced the next step in its surgical robotics development for urology.
By product type, the segment of instruments forms 67.6% of the market share in 2025, growing with the increasing demand for diagnostic and therapeutic urology procedures. Surgical instruments, endoscopes, catheters, and lithotripsy are the primary interventions within urology. Their usage is on the rise due to the increasing prevalence of minimally invasive procedures, as these provide greater precision and result in superior patient outcomes.
They are needed for both routine and complex urology procedures, hence their importance to hospitals and clinics. While they enjoy higher cost-per-unit compared to consumables and accessories, long lifespan due to multiprocedure usage makes their utility long-lasting. Technological improvements like smart endoscopes and AI-assisted imaging devices will further boost their adoption.
For example, in March 2025, Johnson & Johnson MedTech extended its MONARCH robotic-assisted urology system portfolio with the addition of AI-enabled endoscopic tools to improve precision in the performance of kidney stone removal and prostate procedures.
In terms of disease, kidney diseases contribute 36.4% of the market share in 2025, owing to the rising prevalence of kidney stones, chronic kidney disease (CKD), and urinary tract infections globally. The high incidence drives demand for diagnostic, monitoring, and surgical devices tailored to renal care.
Advances in minimally invasive technologies include laser lithotripsy, robotic-assisted nephrolithotomy, and percutaneous nephrostomy devices that are improving treatment options. Many hospitals and clinics adopt such devices due to the advantages associated with quicker recovery times and better patient outcomes.
For example, in September 2025, GMCH Nagpur from India conducted the country's first robotic-assisted kidney transplant in a government facility, highlighting the increased demand and access to cutting-edge, kidney-focused urology devices.
In terms of treatment, minimally invasive/non-invasive devices account for 46.1% share in 2025, fueled by the adoption of robotic and laparoscopic surgeries. These devices reduce procedural complications, shorten hospital stays, and allow faster patient recovery compared to traditional invasive surgeries.
Technological innovations in AI-assisted robotic surgery, smart endoscopes, and real-time monitoring sensors enhance the precision that leads to improved treatment outcomes. They are of special critical importance for delicate procedures in urology, including prostatectomy, nephrolithotomy, and bladder tumor removal.
In terms of end users, hospitals and clinics contribute 68.6% of the market share in 2025, supported by high patient volume and advanced infrastructure. Hospitals are the primary centers for urology procedures, including diagnosis, minimally invasive surgeries, and post-operative care.
Clinics and specialty centers also contribute to the adoption of advanced instruments, robotic systems, and consumables by facilitating outpatient procedures and providing specialized treatments. Investment in training, AI-based surgical assistance, and robotic platforms ensures that operational efficiency is achieved and patient outcomes are enhanced.
For example, AIIMS Jodhpur organized RUFCON 2025 in February 2025, a demonstration of AI and robotic-assisted urology procedures for about 200 healthcare professionals, further reinforcing a hospital's central role in technology adoption.
To learn more about this report, Download Free Sample
North America is set to lead the global urology devices market with 42.7% share in 2025, driven by strong demand from hospitals, clinics, and specialty healthcare centers. The region benefits from advanced healthcare infrastructure, high adoption of minimally invasive and robotic-assisted urology devices, and significant investments in research and development by major medical device companies. In particular, the U.S. has a highly established network of hospitals and surgical centers with advanced diagnostic and therapeutic equipment in the urology department.
For instance, in April 2025, Medtronic’s Hugo RAS system met safety and effectiveness endpoints in its U.S. clinical trial, and the company submitted Hugo for FDA urologic indication.
Asia Pacific is anticipated to be the fastest growing regional market for urology devices over the forecast period. Rapid urbanization, increasing healthcare spending, and growing awareness about urological disorders are driving market expansion in countries such as China, India, Japan, and South Korea. Rising prevalence of kidney diseases, urinary tract infections, and urological cancers, combined with an expanding geriatric population, is spurring demand for both diagnostic and therapeutic urology devices. Hospitals and clinics in the region are increasingly investing in minimally invasive and robotic-assisted technologies to meet rising patient demand and improve treatment outcomes.
For instance, in September 2025, idsMED introduced a new robotic urology system (from EDGE Medical) at the Indonesian Urological Association (ASMIUA) 2025 meeting, highlighting advancing adoption of robotic surgery in Indonesia.
The U.S. urology devices market is exhibiting strong growth in 2025, with an increasingly widespread implementation of robotic-assisted surgeries, AI-enabled diagnostics, and minimally invasive instrumentation. The advanced imaging systems, smart endoscopes, and precision surgical tools are increasingly being integrated into hospitals and surgical centers to improve patient outcomes and reduce recovery time. Strong healthcare infrastructure, high per-capita spending on healthcare, and established reimbursement frameworks further accelerate demand for innovative urology solutions.
For instance, in April 2025, Medtronic announced that its Hugo™
China’s urology devices market is rapidly expanding in 2025, fueled by rising prevalence of kidney stones, BPH, and other urinary disorders, alongside an aging population. Hospitals across both urban and regional areas are adopting modern diagnostic and surgical tools, including endoscopes, laser lithotripsy systems, and robotic-assisted instruments. Moreover, government initiatives and support for healthcare infrastructure development and incentives for local manufacturing and promoting cost-effective solutions are driving the adoption at all tiers of care.
For instance, in March 2025, MicroPort MedBot’s Toumai SP Laparoscopic Surgical Robot received market approval from China’s regulatory authority National Medical Products Administration (NMPA) for clinical use, including in urology, gynecology and general surgery.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 20,153.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.85% | 2032 Value Projection: | USD 28,075.4 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Stryker Corporation, Richard Wolf, Olympus Corporation, Medtronic, Karl Storz, Fresenius Medical Care, Dornier Medtech, Cook Medical, Boston Scientific, and Becton, Dickinson and Company (C.R. Bard). |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
One of the key factors expected to augment the growth of the global urology device market during the forecast period is the growing incidence of urologic conditions worldwide. Such a high burden of urologic diseases leads to an increase in demand for urology devices, driving the market growth. According to the National Institute of Health (NIH), urinary tract infections (UTIs) are some of the most common bacterial infections, affecting around 150 million people each year worldwide.
Rise in demand or adoption of urology devices across the world is expected to provide significant growth opportunities for players in the global urology device market. For instance, with the rise in prevalence or incidence of urologic diseases and increase in awareness among people, the demand for safe and effective urology devices is also increasing with a rapid pace. In January 2023, Cook Medical announced the launch of streamlined portfolio of urological bipolar electrodes in the U.S. to help physicians focus on treating patients with products they use frequently. The electrodes are for daily use in bladder and prostate procedures.
The global urology device market is entering a period of technological consolidation and precision-driven innovation. The adoption of robotic-assisted and AI-enabled systems is no longer incremental but is fast becoming the de facto standard in advanced healthcare institutions. Clinical data indicate that robotic-assisted procedures for prostatectomy and kidney stone removal reduce complication rates by over 30% compared to conventional laparoscopy, while patient recovery times are shortened by an average of 25%.
The aggressive expansion of robotic-assisted capabilities by hospitals and clinics in North America and China reflects demand-side pressure from patient expectations and supply-side availability of high-precision devices.
Ultimately, commercial and clinical leadership in the urology devices market is dictated by precision, intelligence, and workflow integration. The companies that can demonstrate enhanced procedural efficacy, safety, and patient satisfaction-supported by provable clinical outcomes-will define the leading edge of competition, while laggards will be at risk of marginalization in an increasingly evidence-based adoption and technologically differentiated environment.
Definition: Urology devices are used to diagnose and treat urologic diseases/disorders of both male and female urinary tract. Millions of people worldwide are affected by urinary tract system disorders, and women are more likely to be affected than men. Thus, there is an increase in demand for such devices across the world, driving the market growth.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
